Staphylococcus aureus decolonization for recurrent skin and soft tissue infections in children

Canadian Family Physician

Volumn 58, Issue 12, 2012, Pages 1350-1352

  Smith, Christine H ^a   Goldman, Ran D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; DOXYCYCLINE; PSEUDOMONIC ACID; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; DISINFECTION; ERADICATION THERAPY; HEALTH EDUCATION; HUMAN; HYGIENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; REVIEW; RISK REDUCTION; SOFT TISSUE INFECTION; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS SKIN AND SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS SKIN AND SOFT TISSUE INFECTIONS;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; ANTISEPSIS; CHILD; DRUG RESISTANCE, BACTERIAL; HUMANS; MUPIROCIN; RECURRENCE; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84872060182     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Hersh AL, Chambers HF, Maselli JH, Gonzales R. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med 2008;168(14):1585-91.
2. Fritz SA, Hogan PG, Hayek G, Eisenstein KA, Rodriguez M, Epplin EK, et al. Household versus individual approaches to eradication of community-associated Staphylococcus aureus in children: a randomized trial. Clin Infect Dis 2012;54(6):743-51. Epub 2011 Dec 23.
3. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006;355(7):666-74.
4. Adam HJ, Allen VG, Currie A, McGeer AJ, Simor AE, Richardson SE, et al. Community-associated methicillin-resistant Staphylococcus aureus: prevalence in skin and soft tissue infections at emergency departments in the Greater Toronto Area and associated risk factors. CJEM 2009;11(5):439-46.
5. Chen AE, Cantey JB, Carroll KC, Ross T, Speser S, Siberry GK. Discordance between Staphylococcus aureus nasal colonization and skin infections in children. Pediatr Infect Dis J 2009;28(3):244-6.
6. Duong M, Markwell S, Peter J, Barenkamp S. Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient. Ann Emerg Med 2010;55(5):401-7. Epub 2009 May 5.
7. Fritz SA, Epplin EK, Garbutt J, Storch GA. Skin infection in children colonized with community-associated methicillin-resistant Staphylococcus aureus. J Infect 2009;59(6):394-401. Epub 2009 Sep 9.
8. Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005;5(12):751-62.
9. Fritz SA, Garbutt J, Elward A, Shannon W, Storch GA. Prevalence of and risk factors for community-acquired methicillin-resistant and methicillin-sensitive Staphylococcus aureus colonization in children seen in a practice-based research network. Pediatrics 2008;121(6):1090-8.
10. Gorwitz RJ, Kruszon-Moran D, McAllister SK, McQuillan G, McDougal LK, Fosheim GE, et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 2008;197(9):1226-34.
11. Ammerlaan HS, Kluytmans JA, Wertheim HF, Nouwen JL, Bonten MJ. Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. Clin Infect Dis 2009;48(7):922-30.
12. Simor AE, Phillips E, McGeer A, Konvalinka A, Loeb M, Devlin HR, et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 2007;44(2):178-85. Epub 2006 Dec 14.
13. Robinson JL, Salvadori MI. Management of community-associated methicillin-resistant Staphylococcus aureus skin abscesses in children. Paediatr Child Health (Oxford) 2011;16(2):115-8.
14. Fritz SA, Camins BC, Eisenstein KA, Fritz JM, Epplin EK, Burnham CA, et al. Effectiveness of measures to eradicate Staphylococcus aureus carriage in patients with community-associated skin and soft-tissue infections: a randomized trial. Infect Control Hosp Epidemiol 2011;32(9):872-80.
15. Leski T, Oliveira D, Trzcinski K, Sanches IS, Aires de Sousa M, Hryniewicz W, et al. Clonal distribution of methicillin-resistant Staphylococcus aureus in Poland. J Clin Microbiol 1998;36(12):3532-9.
16. Schmitz FJ, Lindenlauf E, Hofmann B, Fluit AC, Verhoef J, Heinz HP, et al. The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals. J Antimicrob Chemother 1998;42(4):489-95.
17. Han LL, McDougal LK, Gorwitz RJ, Mayer KH, Patel JB, Sennott JM, et al. High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center. J Clin Microbiol 2007;45(4):1350-2. Epub 2007 Feb 7.
18. Sladden MJ, Johnston GA. Current options for the treatment of impetigo in children. Expert Opin Pharmacother 2005;6(13):2245-56.